Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: vds4 who wrote (94599)	10/24/2001 3:11:54 PM
From: Jim Bishop	Read Replies (1) \| Respond to of 150070

ACAM LIST stock news DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant Exclusive Patent License; Acambis, Inc. Washington, DC, Oct 24, 2001 (FedNet via COMTEX) -- The Department of the Navy hereby gives notice of its intent to grant to Acambis, Inc., a revocable, nonassignable, exclusive license to practice worldwide the Government-owned inventions described in U.S. Patent application Serial No. 09/439,311, entitled "A Recombinant Polypeptide for Use in the Manufacture of Vaccines Against Campylobacter Induced Diarrhea and to Reduce Colonization" filed November 14, 1998, and its PCT serial number US99/27195 in the field of vaccines against Campylobacter associated disease. DATES: Anyone wishing to object to the grant of this license has fifteen (15) days from the date of this notice to file written objections along with supporting evidence, if any. AGENCY: Department of the Navy, DOD. ACTION: Notice. Copyright 2001 FedNet -0- * end of story *